R. Scott Raynovich

R. Scott Raynovich
Contributor since: 2008
Company: The Rayno Report
Synaptics Is Really Cheap
Tech Earnings Picks and Pans
Sticking With Microsoft
The Best Biotech Takeover Targets
An IPO Roadmap for Twitter
Who Will Stomach Palm's Ugly Numbers?
Ebix: Fast Growth, Low P/E
The End of the Biotech Rally
Prescribing a Hold on Cubist
H1N1: What It Means for Pharma
Biotech: Q3 Market Update
Expect a Short-Lived Dollar Rebound